FDA Approves Breakthrough Eye Drops That Fix Near Vision Without Glasses Key Takeaways Aspect Details Latest FDA Approval VIZZ eye drops approved July 2025, works up to 10 hours Active Ingredient Aceclidine 1.44% - first of its kind in the US How Long It Works Up to 10 hours per dose with once-daily application Effectiveness 71% of users gained 3+ lines of near vision improvement Availability Expected launch between October-December 2025 Other Options Vuity (pilocarpine) and QLOSI also FDA-approved Who Can Use It Adults with presbyopia (age-related near vision loss) Cost Coverage Insurance coverage varies, prescription required What Are These Revolutionary Eye Drops? The FDA just approved VIZZ, the first and only aceclidine-based eye drop for treating presbyopia, marking a global first in this treatment category. This isn't your grandfather's reading glasses solution - we're talking about drops that can give you clear near vision for up to 10 hours with just one d...
Finance Foggle is a free financial data article platform launched in 2006 (revamped in 2022). It provides top financial news, real-time market data, and portfolio tools for retail investors, students, and professionals. Its mission is to democratize financial information by integrating unique search capabilities with market analytics.